Coinjection with TLR2 agonist Pam3CSK4 reduces the pathology of leishmanization in mice. (Q35571431)
Jump to navigation
Jump to search
scientific article published on 4 March 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | Coinjection with TLR2 agonist Pam3CSK4 reduces the pathology of leishmanization in mice. |
scientific article published on 4 March 2015 |
Statements
Coinjection with TLR2 agonist Pam3CSK4 reduces the pathology of leishmanization in mice (English)
Meleana Hinchman
4 March 2015
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference